Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn1r88 Inhibitors

Vmn1r88 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the Vmn1r88 receptor, a member of the V1R family of vomeronasal receptors. These receptors are primarily involved in the detection of pheromones and play a crucial role in the communication of chemical signals between organisms, particularly in vertebrates. Vmn1r88 is part of the extensive family of G-protein-coupled receptors (GPCRs), which are responsible for various signaling pathways within the body. Inhibitors of this receptor are designed to disrupt the interaction between Vmn1r88 and its associated ligands, preventing the receptor from carrying out its usual signaling functions.

The structural characteristics of Vmn1r88 inhibitors are typically designed to mimic the natural ligands of the receptor, allowing them to bind competitively and block activation. These inhibitors may contain diverse chemical scaffolds, such as heterocyclic structures or aromatic rings, to optimize binding affinity and selectivity for the Vmn1r88 receptor. By inhibiting this receptor, these compounds can modulate the signaling processes associated with pheromone detection, potentially altering the behavior or physiological responses related to Vmn1r88 activation. The study of such inhibitors contributes to a broader understanding of how V1R receptors interact with their ligands and the underlying mechanisms governing olfactory and pheromonal signaling pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Beta-adrenergic receptor antagonist, potentially modulating GPCR signaling and indirectly affecting Vmn1r88.

Cimetidine

51481-61-9sc-202996
sc-202996A
5 g
10 g
$62.00
$86.00
1
(1)

Histamine H2 receptor antagonist, may alter GPCR-mediated processes potentially impacting Vmn1r88.

Ondansetron

99614-02-5sc-201127
sc-201127A
10 mg
50 mg
$82.00
$333.00
1
(0)

Serotonin receptor antagonist, could affect GPCR signaling pathways, influencing Vmn1r88 indirectly.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$51.00
$171.00
$530.00
2
(1)

Alpha-2 adrenergic receptor antagonist, potentially affecting noradrenergic signaling related to Vmn1r88.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

Angiotensin II receptor antagonist, could modulate GPCR pathways, potentially influencing Vmn1r88 activity.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Calcium channel blocker, may affect calcium signaling pathways, potentially related to Vmn1r88.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

Inhibits Gi/o proteins, potentially affecting GPCR-mediated signaling pathways involved with Vmn1r88.

Amiloride

2609-46-3sc-337527
1 g
$296.00
7
(1)

Sodium channel blocker, might indirectly influence signaling mechanisms relevant to Vmn1r88.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

PI3K inhibitor, could affect downstream signaling pathways that might impact Vmn1r88 function.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

Dopamine receptor antagonist, might influence GPCR-mediated signaling pathways related to Vmn1r88.